No Data
No Data
No Data
No Data
No Data
Truscreen Group Raises Additional NZ$520,000 via Share Placement; Shares Jump 5%
Truscreen Group (ASX:TRU, NZE:TRU) obtained an additional firm commitment from an investor for the placement of 26 million shares at NZ$0.02 each, resulting in a total raise of NZ$520,000, excluding e
MT NewswiresMar 12 23:32 ET
New Zealand Shares Jump on Friday, Fisher & Paykel Healthcare's Chair to Retire
New Zealand shares jumped on Friday's close, tracking their global counterparts, as investors cheered US Federal Reserve Chair Jerome Powell's pronouncements that rate cuts may start within the year.
MT NewswiresMar 7 23:39 ET
TruScreen to Start Clinical Evaluation Trials for Cancer Screening Device
TruScreen (NZE:TRU, ASX:TRU) is set to start clinical evaluation trials in Kenya and Indonesia for its TruScreen cervical cancer device, according to a filing with the New Zealand Stock Exchange on Fr
MT NewswiresMar 7 19:14 ET
Truscreen Close to Raising NZ$500,000
Truscreen Group (ASX:TRU) has secured firm commitments for the sale of 25 million shares at NZ$0.02 apiece, to raise NZ$500,000. Those shares will be issued under the medical device maker's existing 1
MT NewswiresMar 4 06:17 ET
New Zealand Shares Close the Week in the Green; Port of Tauranga's Fiscal H1 Revenue Falls
New Zealand shares inched up on Friday's close after a volatile trading week as investors turned their attention to the Reserve Bank of New Zealand's upcoming policy meeting. The S&P/NZX 50 rose 0.25%
MT NewswiresFeb 22 23:49 ET
Truscreen Group to Offer Pro-Rata Renounceable Rights Issue; Shares Plunge 11%
Truscreen Group (ASX:TRU, NZE:TRU) plans to launch a one-for-three pro-rata renounceable rights issue to raise up to NZ$2.8 million, the medical device firm said on Monday. The rights offer price stan
MT NewswiresFeb 11 23:26 ET
No Data
No Data